Top Markets
Coin of the day
TheraVet S.A. TheraVet S.A.

TheraVet S.A.

ALVET
Rang in Aktien #40005
TheraVet S.A. operates as a veterinary biotechnology firm, delivering... TheraVet S.A. operates as a veterinary biotechnology firm, delivering specialized osteoarticular therapies for animals across Belgium, France, Switzerland, the United Kingdom, and the United States. The company's primary focus is on providing solutions for osteoarthritis, ligament and tendon damage, and bone surgery requirements in felines, canines, and equines. Its product lineup includes BIOCERA-VET, formulated to enhance bone integration and remodeling, and VISCO-VET. The latter is an injectable, hyaluronic acid-based gel that facilitates regeneration, exhibits anti-inflammatory characteristics, boosts the effectiveness of active compounds, and promotes cellular colonization essential for tissue repair. Founded in 2017, TheraVet S.A. has its corporate base situated in Jumet, Belgium.
Aktienkurs
$0.08585084
Zuletzt synchronisiert: 2025-02-24
Marktkapitalisierung
$276.78K
Veränderung (1 Tag)
0.05%
Veränderung (1 Jahr)
0.00%
Land
BE
Handel TheraVet S.A. (ALVET)

Kategorie

Kursverlauf für TheraVet S.A. (ALVET)
Höchster Schlusskurs: $0.09 am 2025-02-01

Niedrigster Schlusskurs: $9.29 am 2021-06-01
Kursverlauf der Aktie von TheraVet S.A. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -24.67%
2024 -92.98%
2023 -41.85%
2022 -59.35%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.15%
KR
$259.89 14.81%
BE